Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		24,435,000
Beginning balance at Dec. 31, 2022	$ 158,378	$ 2	$ 361,689	$ (115)	$ (203,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		42,000
Issuance of common stock upon exercise of stock options	78		78
Share-based compensation expense	11,954		11,954
Issuance of shares under the employee stock purchase plan (in shares)		77,000
Issuance of shares under the employee stock purchase plan	408		408
Unrealized gain (loss) on investments, net of tax	142			142
Net loss	$ (65,765)				(65,765)
Ending balance (in shares) at Dec. 31, 2023	24,554,205	24,554,000
Ending balance at Dec. 31, 2023	$ 105,195	$ 2	374,129	27	(268,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	0
Share-based compensation expense	$ 10,839		10,839
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)		33,000
Issuance of shares under the employee stock purchase plan (in shares)		94,000
Issuance of shares under the employee stock purchase plan	146		146
Unrealized gain (loss) on investments, net of tax	(11)			(11)
Net loss	$ (63,691)				(63,691)
Ending balance (in shares) at Dec. 31, 2024	24,680,708	24,681,000
Ending balance at Dec. 31, 2024	$ 52,478	$ 2	$ 385,114	$ 16	$ (332,654)